FDA Import Refusal 112-1719361-9/1/1 — Sato Pharmaceutical Co., Ltd.
The FDA refused shipment 112-1719361-9/1/1 from Sato Pharmaceutical Co., Ltd. (Taiwan) on Dec 12, 2011. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charges: 118,472,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 12, 2011
- Country
- Taiwan
- Product Category
- Drugs and Biologics
- Product Code
- 60CDQ46 NAPHAZOLINE HCL (ADRENERGIC)
- Charges
- 118,472,75